Product References

Innovative Research's Single Donor Human Complement Serum was recently used in the following study: An AntiC1s Monoclonal, TNT003, Inhibits Complement Activation Induced by Antibodies Against HLAKA Thomas, NM Valenzuela, D Gjertson, A Mulder - American Journal of , 2015 Single donor normal human serum (NHS) was used as source of active complement (IPLA-CSERS; Innovative Research, Novi, MI). Monoclonal and polyclonal antibody sources. HLA-Ab came from two main sources...

Innovative Research's Innovative Grade US Origin Bovine Whole Blood was recently used in the following study: Rapid analysis of synthetic cannabinoids using a miniature mass spectrometer with ambient ionization capabilityQ Ma, H Bai, W Li, C Wang, RG Cooks, Z Ouyang - Talanta, 2015...Bovine whole blood stabilized with EDTAK 2 was purchased from Innovative Research (Novi, MI,USA). Synthetic urine was purchased from CST Technologies (Great Neck, NY, USA). Methanol of HPLC grade was purchased from Mallinckrodt (Hazelwood, MO, USA)...

Innovative Research's Pooled Normal Human Serum was recently used in the following study: Chromatographic separation of PTAD-derivatized 25-hydroxyvitamin D 3 and its C-3 epimer from human serum and murine skinMD Teegarden, KM Riedl, SJ Schwartz - Journal of Chromatography B, 2015...Human serum and pooled umbilical cord serum were acquired from Innovative Research (Novi,MI)...in this work satisfies the needs of emerging areas of vitamin D research, as it...

Innovative Research's Human Cord Serum Pooled was recently used in the following study: Chromatographic separation of PTAD-derivatized 25-hydroxyvitamin D 3 and its C-3 epimer from human serum and murine skinMD Teegarden, KM Riedl, SJ Schwartz - Journal of Chromatography B, 2015...Human serum and pooled umbilical cord serum were acquired from Innovative Research (Novi,MI)...in this work satisfies the needs of emerging areas of vitamin D research, as it...

Innovative Research's Innovative Grade US Origin Porcine Plasma was recently used in the following study: Ultrasound-enhanced bevacizumab release from echogenic liposomes for inhibition of atheroma progressionME Klegerman, AK Naji, KJ Haworth, Y Zou, E Golunski - of Liposome Research, 2015... For release studies, one 5-mg BEV-ELIP or FITC-BEV-ELIP aliquot was reconstituted with 0.5 ml of nanopure water and added to 49.5 ml of PBS, human plasma (Innovative Research, Novi, MI) or porcine plasma (Innovative Research).